breast cancer | Medivizor | source: Medivizor | Added Apr 09, 2019
In the News: Tumor Infiltrating Lymphocytes and Breast Cancer
This past week a big announcement came from the National Institutes of Health. Dr. Steven Rosenberg, the leading authority on immunotherapy, a treatment he pioneered that uses a person's own immune cells to fight cancer, told the world about Judy Perkins. In 2003 at age 38, Judy was diagnosed with stage
rheumatoid arthritis | Research | 10 pages | source: Rheumatology International | Added Apr 08, 2019
Etanercept and Abatacept: is there a risk of heart failure in patients with rheumatoid arthritis?
This study investigated the risk of heart failure in patients treated with either etanercept (Enbrel) or abatacept (Orencia) for rheumatoid arthritis (RA). They found that these drugs do not increase the risk of heart failure.
breast cancer | Medivizor | source: Medivizor | Added Apr 06, 2019
Cancer Vaccines
When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill. Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcherrheumatoid arthritis | Medivizor | source: Medivizor | Added Apr 06, 2019
Clinical Trials Today
Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and
rheumatoid arthritis | Research | Treatment | 10 pages | source: The Journal of Rheumatology | Added Apr 01, 2019
Sarilumab for rheumatoid arthritis: what is the patient impact?
This study investigated the effect of sarilumab (Kevzara) on the treatment of rheumatoid (RA).
They found that sarilumab had a greater impact on patients’ lives compared to other treatments.
breast cancer | Research | Lifestyle | 10 pages | source: Cancer | Added Mar 31, 2019
Can exercise improve joint pain after hormone therapy for breast cancer?
This study investigated the effectiveness of exercise therapy to treat joint pain in patients with breast cancer (BC) treated with aromatase inhibitors (AIs).
They found that the overall quality of life was improved after 12 months of exercise therapy in these patients.
rheumatoid arthritis | Research | 10 pages | source: Arthritis Care & Research | Added Mar 30, 2019
csDMARDs vs. TNF inhibitors: which is more cost effective in the treatment of rheumatoid arthritis?
This study investigated the cost-effectiveness of different approaches to treat rheumatoid arthritis.
They found that csDMARDs are as effective as TNF inhibitors and cost less.
rheumatoid arthritis | Research | Treatment | 10 pages | source: Arthritis Care & Research | Added Mar 22, 2019
Is hydroxychloroquine an effective treatment for rheumatoid arthritis?
This study investigated if hydroxychloroquine (HCQ; Plaquenil) is an effective treatment in rheumatoid arthritis (RA).
They found that combining HCQ with other RA drugs improves symptoms.
breast cancer | Research | Treatment | 10 pages | source: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer | Added Mar 19, 2019
Treatment of vaginal atrophy for women with breast cancer
This study determined whether using vitamin D and E suppositories improved symptoms of vaginal atrophy in women with breast cancer treated with tamoxifen (Nolvadex). The study found that using vitamin D and E suppositories decreased feelings of vaginal dryness and pain for these patients.
rheumatoid arthritis | Research | 10 pages | source: Annals of the rheumatic diseases | Added Mar 16, 2019
Early intervention and mortality risk – are there benefits for patients with rheumatoid arthritis?
This study investigated the mortality rates in patients with early rheumatoid arthritis (RA). They found that mortality rates were similar to the general population in these patients.
